The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

CHEMBL1817977     N-butan-2-yl-1-(2- chlorophenyl)-N-methyl...

Synonyms: MOLI001365, AC1L9P7B, PK-11195 C-11, [11C]PK11195, 124236-60-8, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of MOLI001365

  • OBJECTIVE: The objectives of the present study were to assess brain atrophy in multiple sclerosis (MS) patients during different disease stages and to investigate by PET and [11C]PK11195, a marker of microglial activation, the relationship between inflammation, atrophy and clinically relevant measures [1].
  • To investigate the microglial reaction in stroke we used a marker for activated microglia, [11C]PK11195, and PET in five patients with ischemic stroke 5-53 days after infarction [2].
 

High impact information on MOLI001365

 

Chemical compound and disease context of MOLI001365

 

Anatomical context of MOLI001365

  • All patients showed increased [11C]PK11195 binding in the ipsilateral thalamus, indicating the activation of microglia in degenerating projection areas remote from the primary lesion [3].
 

Gene context of MOLI001365

 

Analytical, diagnostic and therapeutic context of MOLI001365

References

  1. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study. Versijpt, J., Debruyne, J.C., Van Laere, K.J., De Vos, F., Keppens, J., Strijckmans, K., Achten, E., Slegers, G., Dierckx, R.A., Korf, J., De Reuck, J.L. Mult. Scler. (2005) [Pubmed]
  2. In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic stroke. Gerhard, A., Neumaier, B., Elitok, E., Glatting, G., Ries, V., Tomczak, R., Ludolph, A.C., Reske, S.N. Neuroreport (2000) [Pubmed]
  3. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Pappata, S., Levasseur, M., Gunn, R.N., Myers, R., Crouzel, C., Syrota, A., Jones, T., Kreutzberg, G.W., Banati, R.B. Neurology (2000) [Pubmed]
  4. Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo pet imaging of neurodegeneration. Belloli, S., Moresco, R.M., Matarrese, M., Biella, G., Sanvito, F., Simonelli, P., Turolla, E., Olivieri, S., Cappelli, A., Vomero, S., Galli-Kienle, M., Fazio, F. Neurochem. Int. (2004) [Pubmed]
  5. Distribution of PK11195 binding sites in porcine brain studied by autoradiography in vitro and by positron emission tomography. Cumming, P., Pedersen, M.D., Minuzzi, L., Mezzomo, K., Danielsen, E.H., Iversen, P., Aagaard, D., Keiding, S., Munk, O.L., Finsen, B. Synapse (2006) [Pubmed]
  6. Quantitative autoradiography using selective radioligands for central and peripheral-type benzodiazepine receptors in experimental Wernicke's encephalopathy: implications for positron emission tomography imaging. Leong, D.K., Oliva, L., Butterworth, R.F. Alcohol. Clin. Exp. Res. (1996) [Pubmed]
  7. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195. Debruyne, J.C., Versijpt, J., Van Laere, K.J., De Vos, F., Keppens, J., Strijckmans, K., Achten, E., Slegers, G., Dierckx, R.A., Korf, J., De Reuck, J.L. Eur. J. Neurol. (2003) [Pubmed]
  8. Semiquantification of the peripheral-type benzodiazepine ligand [11C]PK11195 in normal human brain and application in multiple sclerosis patients. Debruyne, J.C., Van Laere, K.J., Versijpt, J., De Vos, F., Eng, J.K., Strijckmans, K., Santens, P., Achten, E., Slegers, G., Korf, J., Dierckx, R.A., De Reuck, J.L. Acta neurologica Belgica. (2002) [Pubmed]
  9. Increased densities of binding sites for the "peripheral-type" benzodiazepine receptor ligand [3H]PK11195 in vulnerable regions of the rat brain in thiamine deficiency encephalopathy. Leong, D.K., Le, O., Oliva, L., Butterworth, R.F. J. Cereb. Blood Flow Metab. (1994) [Pubmed]
 
WikiGenes - Universities